Cerus Corp (CERS)
1.62
-0.14
(-7.95%)
USD |
NASDAQ |
May 03, 16:00
1.63
+0.01
(+0.62%)
After-Hours: 20:00
Cerus Cash from Financing (Quarterly): 1.183M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 1.183M |
September 30, 2023 | 7.602M |
June 30, 2023 | -0.173M |
March 31, 2023 | 2.061M |
December 31, 2022 | 0.457M |
September 30, 2022 | 1.084M |
June 30, 2022 | 0.202M |
March 31, 2022 | 2.449M |
December 31, 2021 | 12.10M |
September 30, 2021 | 4.581M |
June 30, 2021 | 0.127M |
March 31, 2021 | 17.49M |
December 31, 2020 | 8.287M |
September 30, 2020 | 4.171M |
June 30, 2020 | 10.64M |
March 31, 2020 | 68.68M |
December 31, 2019 | 9.484M |
September 30, 2019 | 13.07M |
June 30, 2019 | 11.80M |
March 31, 2019 | 9.133M |
December 31, 2018 | 6.399M |
September 30, 2018 | 12.39M |
June 30, 2018 | 15.14M |
March 31, 2018 | 58.83M |
December 31, 2017 | 11.33M |
Date | Value |
---|---|
September 30, 2017 | 21.90M |
June 30, 2017 | 10.64M |
March 31, 2017 | -0.879M |
December 31, 2016 | 0.302M |
September 30, 2016 | 8.871M |
June 30, 2016 | 7.529M |
March 31, 2016 | 7.865M |
December 31, 2015 | 6.103M |
September 30, 2015 | 1.111M |
June 30, 2015 | 14.24M |
March 31, 2015 | 76.50M |
December 31, 2014 | 12.93M |
September 30, 2014 | 10.38M |
June 30, 2014 | 11.80M |
March 31, 2014 | 1.331M |
December 31, 2013 | 11.24M |
September 30, 2013 | 1.669M |
June 30, 2013 | -5.106M |
March 31, 2013 | 50.84M |
December 31, 2012 | 2.896M |
September 30, 2012 | 1.781M |
June 30, 2012 | 0.574M |
March 31, 2012 | 9.66M |
December 31, 2011 | 11.54M |
September 30, 2011 | 0.998M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.173M
Minimum
Jun 2023
68.68M
Maximum
Mar 2020
9.226M
Average
4.581M
Median
Sep 2021
Cash from Financing (Quarterly) Benchmarks
Perspective Therapeutics Inc | 0.352M |
Retractable Technologies Inc | -0.1364M |
Xtant Medical Holdings Inc | 0.325M |
Asensus Surgical Inc | 0.172M |
Catheter Precision Inc | -0.107M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -15.18M |
Cash from Investing (Quarterly) | 8.216M |
Free Cash Flow | -47.76M |
Free Cash Flow Per Share (Quarterly) | -0.0837 |
Free Cash Flow to Equity (Quarterly) | -16.40M |
Free Cash Flow to Firm (Quarterly) | -12.83M |
Free Cash Flow Yield | -16.36% |